John Goodchild

2.7k total citations
49 papers, 2.2k citations indexed

About

John Goodchild is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, John Goodchild has authored 49 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 10 papers in Organic Chemistry and 4 papers in Infectious Diseases. Recurrent topics in John Goodchild's work include DNA and Nucleic Acid Chemistry (27 papers), RNA and protein synthesis mechanisms (17 papers) and Advanced biosensing and bioanalysis techniques (12 papers). John Goodchild is often cited by papers focused on DNA and Nucleic Acid Chemistry (27 papers), RNA and protein synthesis mechanisms (17 papers) and Advanced biosensing and bioanalysis techniques (12 papers). John Goodchild collaborates with scholars based in United States, Canada and United Kingdom. John Goodchild's co-authors include Paul C. Zamecnik, Prem S. Sarin, Sudhir Agrawal, M.P. Civeira, Y‐h. Taguchi, Arthur Thornton, Di Sun, T Ikeuchi, Byung Gon Kim and Thomas A. Perkins and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

John Goodchild

49 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Goodchild United States 22 1.7k 298 288 276 184 49 2.2k
Lincoln J. McBride United States 16 1.6k 0.9× 219 0.7× 281 1.0× 136 0.5× 157 0.9× 21 2.1k
Fumio Harada Japan 34 3.1k 1.8× 217 0.7× 121 0.4× 248 0.9× 271 1.5× 82 3.7k
Federico Focher Italy 27 1.0k 0.6× 406 1.4× 267 0.9× 163 0.6× 407 2.2× 95 1.7k
Joseph P. Davide United States 22 1.3k 0.7× 392 1.3× 132 0.5× 508 1.8× 205 1.1× 37 2.1k
Stephen Oroszlan United States 19 828 0.5× 285 1.0× 109 0.4× 374 1.4× 163 0.9× 28 1.6k
R. Crowther United States 18 927 0.5× 112 0.4× 171 0.6× 200 0.7× 292 1.6× 23 1.8k
Geneviève Degols France 23 1.7k 1.0× 168 0.6× 70 0.2× 104 0.4× 136 0.7× 32 2.1k
William Markland United States 20 1.1k 0.6× 288 1.0× 94 0.3× 95 0.3× 441 2.4× 31 2.0k
Brian C. Froehler United States 22 2.3k 1.3× 183 0.6× 527 1.8× 57 0.2× 70 0.4× 31 2.5k
Kurt Morgenstern United States 13 849 0.5× 293 1.0× 72 0.3× 117 0.4× 515 2.8× 19 1.8k

Countries citing papers authored by John Goodchild

Since Specialization
Citations

This map shows the geographic impact of John Goodchild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Goodchild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Goodchild more than expected).

Fields of papers citing papers by John Goodchild

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Goodchild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Goodchild. The network helps show where John Goodchild may publish in the future.

Co-authorship network of co-authors of John Goodchild

This figure shows the co-authorship network connecting the top 25 collaborators of John Goodchild. A scholar is included among the top collaborators of John Goodchild based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Goodchild. John Goodchild is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goodchild, John. (2011). Therapeutic Oligonucleotides. Methods in molecular biology. 8 indexed citations
2.
Goodchild, John. (2011). Therapeutic Oligonucleotides. Methods in molecular biology. 764. 1–15. 47 indexed citations
3.
Goodchild, John. (2003). Optimization of Hammerhead Flanking Sequences Using Oligonucleotide Facilitators. Humana Press eBooks. 74. 265–274. 1 indexed citations
4.
Perkins, Thomas A. & John Goodchild. (2003). Using Fluorescence Resonance Energy Transfer to Investigate Hammerhead Ribozyme Kinetics. Humana Press eBooks. 74. 241–252. 1 indexed citations
5.
Goodchild, John, et al.. (2003). Selection of Accessible Sites for Ribozymes on Large RNA Transcripts. Humana Press eBooks. 74. 37–44. 2 indexed citations
6.
Goodchild, John. (2002). Hammerhead ribozymes for target validation. Expert Opinion on Therapeutic Targets. 6(2). 235–247. 7 indexed citations
7.
Hovig, Eivind, et al.. (2001). Optimization of Hammerhead Ribozymes for the Cleavage of S100A4 (CAPL) mRNA. Antisense and Nucleic Acid Drug Development. 11(2). 67–75. 6 indexed citations
8.
Qiu, Gang, John Goodchild, Robert E. Humphreys, & Minzhen Xu. (1999). Cancer immunotherapy by antisense suppression of Ii protein in MHC-class-II-positive tumor cells. Cancer Immunology Immunotherapy. 48(9). 499–506. 22 indexed citations
9.
Goodchild, John, et al.. (1996). Modulation of Tetraplex Formation by Chemical Modifications of a G4-Containing Phosphorothioate Oligonucleotide. Journal of the American Chemical Society. 118(26). 6301–6302. 9 indexed citations
10.
Goodchild, John, et al.. (1994). Further Studies on the Use of Oligonucleotide Facilitators to Increase Ribozyme Turnover. PubMed. 4(4). 243–249. 9 indexed citations
11.
Li, Congjun, John Goodchild, & Earl F. Baril. (1994). DNA ligase I is associated with the 21 S complex of enzymes for DNA synthesis in HeLa cells. Nucleic Acids Research. 22(4). 632–638. 32 indexed citations
12.
Goodchild, John. (1992). Enhancement of ribozyme catalytic activity by a contiguous oligodeoxynucleotide (facilitator) and by 2′-O-methylation. Nucleic Acids Research. 20(17). 4607–4612. 67 indexed citations
13.
Goodchild, John, Byung Gon Kim, & Paul C. Zamecnik. (1991). The Clearance and Degradation of Oligodeoxynucleotides Following Intravenous Injection into Rabbits. PubMed. 1(2). 153–160. 45 indexed citations
14.
Goodchild, John. (1991). Antisense Antivirals. PubMed. 1(4). 361–364. 8 indexed citations
15.
Goodchild, John & Jamboor K. Vishwanatha. (1991). A novel assay for DNA ligase. Nucleic Acids Research. 19(13). 3745–3745. 2 indexed citations
16.
Goodchild, John. (1991). Antisense nucleic acids and proteins. Cell Biophysics. 18(3). 295–296. 35 indexed citations
17.
Goodchild, John, et al.. (1991). Ribozymes that cleave an RNA sequence from human immunodeficiency virus: The effect of flanking sequence on rate. Archives of Biochemistry and Biophysics. 284(2). 386–391. 61 indexed citations
18.
Goodchild, John. (1990). Conjugates of oligonucleotides and modified oligonucleotides: a review of their synthesis and properties. Bioconjugate Chemistry. 1(3). 165–187. 345 indexed citations
19.
Goodchild, John, et al.. (1988). Inhibition of rabbit β-Globin synthesis by complementary oligonucleotides: Identification of mRNA sites sensitive to inhibition. Archives of Biochemistry and Biophysics. 263(2). 401–409. 40 indexed citations
20.
Goodchild, John, et al.. (1987). Eukaryotic initiation factor 4A stimulates translation in microinjected Xenopus oocytes. Developmental Biology. 121(1). 58–68. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026